Clinical trials: Angiography
Coronary Computed Tomographic Angiography, Myocardial Infarction (MI)
GSI Cardiac on Revolution Apex - US
The goal of this clinical data collection study is to collect raw CT scan data using a new GSI Cardiac mode on GE HealthCare's Revolution Apex CT system.
- Conditions
- Coronary Computed Tomographic Angiography, Myocardial Infarction (MI), Cardiac Catheterization
- Trial name
- NCT06702917
- Testing
- GSI Cardiac Scan, Standard of Care CCTA, Research CCTA
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- GE Healthcare
Retina Condition Followed by Fluorescein Angiography Imaging
OCT Angiography Software Evaluation Study
Comparisons for vascular structure visualization in the retina and choroid.
- Trial name
- NCT04701931
- Testing
- Maestro2 OCTA, Cirrus HD-OCT 5000, TRC-50DX
- Where
- 2 sites in United States
- Volunteers
- 135 people, healthy volunteers welcome
- Sponsor
- Topcon Corporation
Fluorescein Angiography Imaging
Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study
Comparisons for vascular structure visualization in the retina and choroid.
- Trial name
- NCT04201340
- Testing
- DRI OCT Triton with SS-OCT Angio software, Cirrus HD-OCT 5000, TRC-50DX
- Where
- United States
- Volunteers
- 211 people, healthy volunteers welcome
- Sponsor
- Topcon Corporation
Coronary Artery Disease, Artificial Intelligence
Evaluation on the Effectiveness and Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery Stenosis
With the emergence of advanced technology to date in the artificial intelligence (AI), computer aided diagnosis has gradually gained its popularity in the field of healthcare.
- Conditions
- Coronary Artery Disease, Artificial Intelligence, Coronary Artery Stenosis, CT Angiography
- Trial name
- NCT05320185
- Testing
- RuiXin-CoronaryAI software
- Where
- 3 sites in China
- Volunteers
- 615 people
- Sponsor
- Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Medical Need for Fluorescein Angiography Imaging
Triton Fundus Autofluorescence and Fluorescein Angiography
Compare the image quality of the fundus autofluorescence and fluorescein angiography
- Trial name
- NCT03107104
- Testing
- Topcon DRI OCT Triton (plus), TRC-50DX retinal camera
- Where
- United States
- Volunteers
- 47 people, healthy volunteers welcome
- Sponsor
- Topcon Medical Systems, Inc.
Optical Coherence Tomography, Intravascular Ultrasound
OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation
This study is a prospective, multi-center, randomized controlled clinical trial, aims to assess the safety and effectiveness of Optical Coherence Tomography or Intravascular Ultrasound or Quantitative Coronary Analysis to guide…
- Conditions
- Optical Coherence Tomography, Intravascular Ultrasound, Angiography
- Trial name
- NCT03574636
- Testing
- OCT guidance, IVUS guidance, QCA
- Where
- China
- Volunteers
- 375 people
- Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
Contrast-induced Nephropathy, Coronary Angiography
Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection
This study is designed to compare the bioavailability of the test Product(CE-Iohexol Injection) and the reference product Iohexol Injection (Omnipaque™) following intravenous injection in normal healthy volunteers.
- Trial name
- NCT03869983
- Testing
- Omnipaque™ (iohexol) Injection, CE-Iohexol
- Where
- Canada
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- CyDex Pharmaceuticals, Inc.
Angiography, Multidetector Computed Tomography
A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting
The objective of this study is to evaluate the image quality for different iodine delivery rates at different low voltage scanning protocols (80 or 100 kV ) under the modern advanced Multi-Detector Computed Tomography (MDCT)…
- Trial name
- RIGHT (NCT02840903)
- Testing
- Iopromide (Ultravist, BAY86-4877)
- Where
- China
- Volunteers
- 1,214 people
- Sponsor
- Bayer
Coronary Angiography
DyeVert System RCT
The purpose of this study is to evaluate the amount of contrast media (CM) saved using the DyeVert system in diagnostic angiographic procedures compared to a control group.
- Trial name
- NCT02752802
- Testing
- Diagnostic Coronary Angiogram
- Where
- Germany
- Volunteers
- 96 people
- Sponsor
- Osprey Medical, Inc
Coronary Angiography
DyeVert Pilot Trial
The purpose of this study is to evaluate the usability characteristics of DyeVert™ during normal clinical use and to understand the amount of contrast media (CM) diverted from the subject and saved over a total angiographic…
- Trial name
- NCT02606734
- Testing
- Coronary Angiography
- Where
- 2 sites in Australia, Germany
- Volunteers
- 44 people
- Sponsor
- Osprey Medical, Inc
Magnetic Resonance Imaging, Magnetic Resonance Angiography
GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients
Prospective, non-interventional, multi-center study. The observation period for each subject covers the treatment period with Gadovist®.
- Trial name
- GARDIAN (NCT01095081)
- Testing
- Gadobutrol (Gadovist, BAY86-4875)
- Where
- 20 sites in Bosnia and Herzegovina, Canada and 18 more
- Volunteers
- 23,775 people
- Sponsor
- Bayer
Magnetic Resonance Angiography, Peripheral Vascular Diseases
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
The objective of the study was to compare the efficacy of Magnevist (SH L 451 A) at doses of 0.1 mmol/kg and 0.2 mmol/kg in contrast-enhanced 3D-Magnetic Resonance Angiography in three regions (abdominal, femoral, and leg…
- Conditions
- Magnetic Resonance Angiography, Peripheral Vascular Diseases, Peripheral Arterial Diseases
- Trial name
- NCT00652418
- Testing
- Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)
- Where
- 3 sites in Japan
- Volunteers
- 12 people
- Sponsor
- Bayer